APA

Dummer R., Brase J. C., Garrett J., Campbell C. D., Gasal E., Squires M., Gusenleitner D., Santinami M., Atkinson V., Mandalà M., Chiarion-Sileni V., Flaherty K., Larkin J., Robert C., Kefford R., Kirkwood J. M., Hauschild A., Schadendorf D. & Long G. V. (20200706). Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF. : The Lancet. Oncology.

Chicago

Dummer Reinhard, Brase Jan C, Garrett James, Campbell Catarina D, Gasal Eduard, Squires Matthew, Gusenleitner Daniel, Santinami Mario, Atkinson Victoria, Mandalà Mario, Chiarion-Sileni Vanna, Flaherty Keith, Larkin James, Robert Caroline, Kefford Richard, Kirkwood John M, Hauschild Axel, Schadendorf Dirk and Long Georgina V. 20200706. Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF. : The Lancet. Oncology.

Harvard

Dummer R., Brase J. C., Garrett J., Campbell C. D., Gasal E., Squires M., Gusenleitner D., Santinami M., Atkinson V., Mandalà M., Chiarion-Sileni V., Flaherty K., Larkin J., Robert C., Kefford R., Kirkwood J. M., Hauschild A., Schadendorf D. and Long G. V. (20200706). Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF. : The Lancet. Oncology.

MLA

Dummer Reinhard, Brase Jan C, Garrett James, Campbell Catarina D, Gasal Eduard, Squires Matthew, Gusenleitner Daniel, Santinami Mario, Atkinson Victoria, Mandalà Mario, Chiarion-Sileni Vanna, Flaherty Keith, Larkin James, Robert Caroline, Kefford Richard, Kirkwood John M, Hauschild Axel, Schadendorf Dirk and Long Georgina V. Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF. : The Lancet. Oncology. 20200706.